𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function

✍ Scribed by Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Ciarka, A.; Droogné, W.; Van Cleemput, J.; Belmans, A.; Meyns, B.; Vanhaecke, J.

Book ID
122132472
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
163 KB
Volume
33
Category
Article
ISSN
1557-3117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of late co
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Improvement of renal function after the
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction
✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro